[1]CAO W,CHEN HD,YU YW,et al.Changing profiles of cancer burden worldwide and in China:a secondary analysis of the global cancer statistics 2020[J].Chinese Medical Journal,2021,134(7):783-791.
[2]STROHMAIER S,EDLINGER M,MANJER J,et al.Total serum cholesterol and cancer incidence in the metabolic syndrome and cancer project(Me-Can)[J].PLoS One,2013,8(1):e54242.
[3]HIS M,ZELEK L,DESCHASAUX M,et al.Prospective associations between serum biomarkers of lipid metabolism and overall,breast and prostate cancer risk[J].European Journal of Epidemiology,2014,29(2):119-132.
[4]BORGQUIST S,BUTT T,ALMGREN P,et al.Apolipoproteins,lipids and risk of cancer[J].International Journal of Cancer,2016,138(11):2648-2656.
[5]胡北平,汪天培,朱猛,等.血脂水平和遗传因素与男性肿瘤发病风险关联[J].中华疾病控制杂志,2021,25(09):1003-1007.HU BP,WANG TP,ZHU M,et al.Association of blood lipid and genetic factor with cancer risk in men[J].Chinese Journal of Disease Control and Prevention,2021,25(09):1003-1007.
[6]CALLING S,JOHANSSON SE,WOLFF M,et al.Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease:a 17-year follow-up study of women in southern Sweden[J].BMC Cardiovascular Disorders,2021,21(1):163.
[7]GUAN XM,WU SL,YANG XL,et al.Association of total cholesterol,low-density lipoprotein cholesterol,and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population[J].International Journal of Cancer,2018,142(6):1209-1217.
[8]TANG M,ZHAO Q,YI K,et al.Association between four nontraditional lipids and ischemic stroke:a cohort study in Shanghai,China[J].Lipids in Health and Disease,2022,21(1):72.
[9]于洋杰,谢坤,高秀芳,等.非高密度脂蛋白胆固醇可以替代低密度脂蛋白胆固醇吗[J].心血管病学进展,2021,42(01):12-16.YU YJ,XIE K,GAO XF,et al.Can LDL-Cbe replaced by non-HDL-C[J].Advances in Cardiovascular Diseases,2021,42(01):12-16.
[10]牛松涛,王安心,吴建维,等.非高密度脂蛋白胆固醇水平与周围动脉疾病的相关性研究[J].中国卒中杂志,2021,16(6):590-595.NIU ST,WANG AX,WU JW,et al.Association between non-high-density lipoprotein cholesterol level and peripheral artery disease[J].Chinese Journal of Stroke,2021,16(6):590-595.
[11]RIDKER PM,RIFAI N,COOK NR,et al.Non-HDL cholesterol,apolipoproteins A-I and B100,standard lipid measures,lipid ratios,and CRP as risk factors for cardiovascular disease in women[J].JAMA,2005,294(3):326-333.
[12]李莹,陈志红,周北凡,等.我国中年人群血清TC/HDL-C比值与缺血性和出血性脑卒中发病危险性[J].中华神经科杂志,2005,38(05):305-308.LI Y,CHEN ZH,ZHOU BF,et al.Serum TC/HDL-C ratio and the risk of ischemic and hemorrhagic stroke incidence in middle aged Chinese population[J].Chinese Journal of Neurology,2005,38(05):305-308.
[13]WADSTRM BN,WULFF AB,PEDERSEN KM,et al.Elevated remnant cholesterol increases the risk of peripheral artery disease,myocardial infarction,and ischaemic stroke:a cohort-based study[J].European Heart Journal,2022,43(34):3258-3269.
[14]HOLMES MV,MILLWOOD IY,KARTSONAKI C,et al.Lipids,lipoproteins,and metabolites and risk of myocardial infarction and stroke[J].Journal of the American College of Cardiology,2018,71(6):620-632.
[15]KATZKE VA,SOOKTHAI D,JOHNSON T,et al.Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort[J].BMC Medicine,2017,15(1):218.
[16]CHOWDHURY FA,ISLAM MF,PROVA MT,et al.Association of hyperlipidemia with breast cancer in Bangladeshi women[J].Lipids in Health and Disease,2021,20(1):52.
[17]赵琦,姜永根,王娜,等.上海市郊区自然人群队列和生物样本库建设[J].中华流行病学杂志,2023,44(1):28-33.ZHAO Q,JIANG YG,WANG N,et al.Establishment of Shanghai suburban adult cohort and biobank[J].Chinese Journal of Epidemiology,2023,44(1):28-33
[18] ZHAO Q,CHEN B,WANG RP,et al.Cohort profile:protocol and baseline survey for the Shanghai Suburban Adult Cohort and Biobank(SSACB) study[J].BMJ Open,2020,10(7):e035430.
[19]朱之鑫,朱向东,卢春恒.《中国2000年全国人口普查资料》[M].北京:中国统计出版社,2002:35.ZHU ZX,ZHU XD,LU CH.Tabulation on the 2000 population census of the Peoples Republic of China[M].Beijing:China Statistic Press,2002:35.
[20]MARTIN LJ,MELNICHOUK O,HUSZTI E,et al.Serum lipids,lipoproteins,and risk of breast cancer:a nested case-control study using multiple time points[J].Journal of the National Cancer Institute,2015,107(5):djv032.
[21]QIU X,LI Y,MA M,et al.Novel application of the traditional lipid ratios as strong risk predictors of nonsmall-cell lung cancer risk in a Chinese population[J].Medicine,2022,101(35):e30230.
[22]AGONGO G,RAAL F,NONTERAH EA,et al.Non-HDL-C and LDL-C/HDL-C are associated with self-reported cardiovascular disease in a rural West African population:Analysis of an array of lipid metrics in an AWI-Gen sub-study[J].PLoS One,2022,17(12):e0278375.
[23]SHOJI T,MASAKANE I,WATANABE Y,et al.Elevated non-high-density lipoprotein cholesterol(non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients[J].Clinical Journal of the American Society of Nephrology,2011,6(5):1112-1120.
[24]李超,白明,彭瑜,等.非高密度脂蛋白胆固醇与冠状动脉病变严重程度的相关性[J].中国动脉硬化杂志,2019,27(4):344-348.LI C,BAI M,PENG Y,et al.Correlation of non-high density lipoprotein cholesterol levels and artery atherosclerosis severity[J].Chinese Journal of Arteriosclerosis,2019,27(4):344-348.
[25]刘洋,郭阳.非高密度脂蛋白胆固醇(non-HDL-C)与颅内外动脉硬化狭窄的关系[J].中风与神经疾病杂志,2016,33(10):890-893.LIU Y,GUO Y.Association between non-high-density-lipoprotein-cholesterol levels and intracranial and extracranial atherosclerosis[J].Journal of Apoplexy and Nervous Diseases,2016,33(10):890-893.
[26]PATEL KK,KASHFI K.Lipoproteins and cancer:The role of HDL-C,LDL-C,and cholesterol-lowering drugs[J].Biochemical Pharmacology,2022,196:114654.
[27]KING RJ,SINGH PK,MEHLA K.The cholesterol pathway:impact on immunity and cancer[J].Trends in Immunology,2022,43(1):78-92.
[28]KUZU OF,NOORY MA,ROBERTSON GP.The role of cholesterol in cancer[J].Cancer Research,2016,76(8):2063-2070.
[29]MURAI T,MARUYAMA Y,MIO K,et al.Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration[J].The Journal of Biological Chemistry,2011,286(3):1999-2007.
[30]NAGO N,ISHIKAWA S,GOTO T,et al.Low cholesterol is associated with mortality from stroke,heart disease,and cancer:the Jichi Medical School cohort study[J].Journal of Epidemiology,2011,21(1):67-74.
[31]BLUM MR,POPAT RA,NAGY A,et al.Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome[J].Journal of Endocrinological Investigation,2021,44(10):2123-2130.
[32]CHIEFARI E,MIRABELLI M,LA VIGNERA S,et al.Insulin resistance and cancer:in search for a causal link[J].International Journal of Molecular Sciences,2021,22(20):11137.
[33]LYU Z,LI N,WANG G,et al.Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males:A prospective cohort study[J].International Journal of Cancer,2019,144(12):2972-2984.